Medicine and Dentistry
Mineralocorticoid Antagonist
100%
Clinical Trial
44%
Drug Therapy
33%
Diabetic Nephropathy
22%
Heart Failure
22%
Albuminuria
22%
Brain Natriuretic Peptide
22%
Receptor
11%
Cardiovascular System
11%
Diseases
11%
Serositis
11%
Serum
11%
Hypertension
11%
Nephropathy
11%
Potassium
11%
Proteinuria
11%
Aldosterone
11%
Mineralocorticoid Receptor
11%
Pathology
11%
Mechanism of Action
11%
Medication
11%
Inpatient
11%
Heart Failure
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mineralocorticoid Antagonist
100%
Finerenone
66%
Diabetic Nephropathy
22%
Albuminuria
22%
Heart Failure
22%
Receptor
11%
Diseases
11%
Hypertension
11%
Potassium
11%
Kidney Disease
11%
Proteinuria
11%
Aldosterone
11%
Mineralocorticoid Receptor
11%